Jason Shohet MD Ph.D.
Associate Professor, Pediatric Oncology, Baylor College of Medicine
Join to View Full Profile
55 Lake Ave NWorcester, MA 01655
Phone+1 774-441-8083
Fax+1 774-441-8057
Dr. Shohet is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Southwestern Medical CenterFellowship, Pediatric Hematology/Oncology, 1996 - 1999
Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 1995 - 1996- Baylor College of Medicine (Houston)Residency, Pediatrics, 1993 - 1995
Boston University School of MedicineClass of 1993
Certifications & Licensure
MA State Medical License 1999 - 2026
ME State Medical License 2023 - 2025
TX State Medical License 2000 - 2025
American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Investigation of Cell Mechanics and Migration on DDR2-Expressing Neuroblastoma Cell Line.Theadora Vessella, Esteban J Rozen, Jason Shohet, Qi Wen, Hong Susan Zhou
Life. 2024-10-02 - 1 citationsBlockade of Discoidin Domain Receptor Signaling with Sitravatinib Reveals DDR2 as a Mediator of Neuroblastoma Pathogenesis and Metastasis.Esteban J Rozen, William Frantz, Kim Wigglesworth, Theadora Vessella, Hong S Zhou
Molecular Cancer Therapeutics. 2024-08-01 - 2 citationsDDR2 signaling and mechanosensing orchestrate neuroblastoma cell fate through different transcriptome mechanisms.Theadora Vessella, Steven Xiang, Cong Xiao, Madelyn Stilwell, Jaidyn Fok
FEBS Open Bio. 2024-05-01
Other
- Clinical presentation, diagnosis, and staging evaluation of neuroblastomaShohet JM, Russell HV, Nuchtern JG
http://www.uptodate.com/contents/clinical-presentation-diagnosis-and-staging-evaluation-of-neuroblas
UpToDate, Wolters Kluwer Health - 2012-05-30 - Epidemiology, pathogenesis, and pathology of neuroblastomaShohet JM, Russell HV, Nuchtern JG
http://www.uptodate.com/contents/epidemiology-pathogenesis-and-pathology-of-neuroblastoma
UpToDate, Wolters Kluwer Health - 2012-05-29 - Treatment and prognosis of neuroblastomaShohet JM, Russell HV, Nuchtern JG
http://www.uptodate.com/contents/treatment-and-prognosis-of-neuroblastoma
UpToDate, Wolters Kluwer Health - 2013-03-27
Press Mentions
An ALYREF-MYCN Coactivator Complex Drives Neuroblastoma Tumorigenesis Through Effects on USP3 and MYCN StabilityMarch 25th, 2021- A Novel Combination Therapy Targeting Ubiquitin-Specific Protease 5 in MYCN-Driven NeuroblastomaMarch 3rd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
